HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prolonged severe neutropenia after the first daratumumab administration for multiple myeloma with baseline neutropenia.

AuthorsFumihiko Nakamura, Ryo Nasu
JournalAnnals of hematology (Ann Hematol) Vol. 98 Issue 9 Pg. 2231-2232 (Sep 2019) ISSN: 1432-0584 [Electronic] Germany
PMID31098738 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • daratumumab
Topics
  • Aged
  • Antibodies, Monoclonal (administration & dosage, adverse effects)
  • Female
  • Humans
  • Multiple Myeloma (drug therapy, metabolism, pathology)
  • Neutropenia (chemically induced, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: